V. Vlassov

V. Vlassov, P. Laktionov, E. Rykova, 2011, European journal of cancer prevention : the official journal of the European Cancer Prevention Organisation.

Cell‐Surface‐Bound Circulating DNA as a Prognostic Factor in Lung Cancer

V. Vlassov, P. Laktionov, E. Rykova, 2008, Annals of the New York Academy of Sciences.

Tumoricidal Activity of RNase A and DNase I

V. Vlassov, M. Zenkova, E. Ryabchikova, 2010, Acta naturae.

New Approaches for Cancer Treatment: Antitumor Drugs Based on Gene-Targeted Nucleic Acids

V. Vlassov, M. Zenkova, N. Mironova, 2009, Acta naturae.

Cell‐Surface‐Bound Nucleic Acids: Free and Cell‐Surface‐Bound Nucleic Acids in Blood of Healthy Donors and Breast Cancer Patients

A. V. Starikov, V. Vlassov, P. Laktionov, 2004, Annals of the New York Academy of Sciences.

Site-specific cleavage of single-stranded DNAs at unique sites by a copper-dependent redox reaction

V. Vlassov, S. Kazakov, S. Mamaev, 1988, Nature.

Incorporation of Antisense Oligonucleotides into Lipophilic Concatemeric Complexes Provides Their Effective Penetration into Cells

V. Vlassov, M. Zenkova, A. G. Venyaminova, 2019, Russian Journal of Bioorganic Chemistry.

A mechanism of the toxicity of artificial ribonucleases for human cancer cells

V. Vlassov, M. Zenkova, E. Ryabchikova, 2010 .

Methylation‐Based Analysis of Circulating DNA for Breast Tumor Screening

V. Vlassov, G. Tsvetovskaya, P. Laktionov, 2008, Annals of the New York Academy of Sciences.

Binary hammerhead ribozymes with improved catalytic activity.

M. Vorobjeva, V. Vlassov, A. Venyaminova, 2006, Oligonucleotides.

MODIFIED BINARY HAMMERHEAD RIBOZYMES WITH HIGH CATALYTIC ACTIVITY

M. Vorobjeva, V. Vlassov, A. Venyaminova, 2005, Nucleosides, nucleotides & nucleic acids.

Sequence-specific chemical modification of double-stranded DNA with alkylating oligodeoxyribonucleotide derivatives.

V. Vlassov, O. Fedorova, V. Zarytova, 1988, Gene.

Binding and Penetration of Methylated DNA into Primary and Transformed Human Cells

V. Vlassov, P. Laktionov, T. Skvortsova, 2008, Annals of the New York Academy of Sciences.

Investigation of tumor-derived extracellular DNA in blood of cancer patients by methylation-specific PCR.

A. V. Starikov, V. Vlassov, P. Laktionov, 2004 .

c‐fos gene expression in cell revertants from a transformed to a pseudonormal phenotype

V. Vlassov, F. Svinarchuk, Y. Lavrovsky, 1993, FEBS letters.

Cholesterol-modified anti-MDR1 small interfering RNA: Uptake and biological activity

V. Vlassov, A. Venyaminova, M. Zenkova, 2010, Molecular Biology.

The tertiary structure of yeast tRNAPhe in solution studied by phosphodiester bond modification with ethylnitrosourea

V. Vlassov, J. Ebel, R. Giegé, 1980, FEBS letters.

The extracellular domain of CD4 receptor possesses a protein kinase activity

V. Vlassov, C. Stein, L. Yakubov, 1998, FEBS letters.

INTERACTION OF OLIGONUCLEOTIDES WITH CELLULAR PROTEINS

V. Vlassov, B. Chelobanov, P. Laktionov, 2001, Nucleosides, nucleotides & nucleic acids.

Bulge-Forming miRNases Cleave Oncogenic miRNAs at the Central Loop Region in a Sequence-Specific Manner

V. Vlassov, M. Zenkova, O. Patutina, 2022, International journal of molecular sciences.

A Comparison of Target Gene Silencing using Synthetically Modified siRNA and shRNA That Express Recombinant Lentiviral Vectors

V. Prassolov, V. Vlassov, M. Zenkova, 2009, Acta naturae.

Involvement of the D‐stem of tRNAPhe (E. coli) in interaction with phenylalanyl‐tRNA synthetase as shown by chemical modification

V. Vlassov, V. Vlassov, N. Melamed, 1975, FEBS letters.

Antisense oligonucleotide gapmers containing phosphoryl guanidine groups reverse MDR1-mediated multiple drug resistance of tumor cells

I. V. Chernikov, D. Pyshnyi, S. Altman, 2021, Molecular therapy. Nucleic acids.

Structural studies by high-field NMR spectroscopy of a binary-addressed complementary oligonucleotide system juxtaposing pyrene and perfluoro-azide units.

D. Marks, V. Vlassov, K. Douglas, 1997, Journal of biomolecular structure & dynamics.

Site-specific modification of the 5"-terminal fragment of PGY1/MDR1 gene mRNA by reactive conjugates of antisense oligonucleotides

V. Vlassov, A. Venyaminova, M. Zenkova, 2003 .

Porphyrin‐linked oligonucleotides

V. Vlassov, E. Frolova, E. Ivanova, 1990, FEBS letters.

Isolation and Comparative Study of Cell‐Free Nucleic Acids from Human Urine

A. V. Starikov, V. Vlassov, P. Laktionov, 2006, Annals of the New York Academy of Sciences.

Synthesis of novel 2-cyano substituted glycyrrhetinic acid derivatives as inhibitors of cancer cells growth and NO production in LPS-activated J-774 cells.

V. Vlassov, M. Zenkova, N. Salakhutdinov, 2014, Bioorganic & medicinal chemistry.

Sensitized site-specific photomodification of ssDNA by binary systems of oligonucleotide conjugates: VI. Effect of substituents in the sensitizer anthracene residue

V. Vlassov, M. Dobrikov, T. I. Gainutdinov, 2000, Russian Journal of Bioorganic Chemistry.

Design and synthesis of artificial ribonucleases based on 1,4-diazabicyclo[2.2.2]octane and imidazole

V. Vlassov, V. Silnikov, I. E. Beck, 2002 .

Sensitized photomodification of oligonucleotide-binding proteins displayed on the eucaryotic cell surface

V. Vlassov, L. Yakubov, M. Dobrikov, 2002 .

Influence of Caudovirales Phages on Humoral Immunity in Mice

V. Vlassov, A. Chechushkov, N. Tikunova, 2021, Viruses.

Complementary addressed reagents carrying EDTA‐Fe(II) groups for directed cleavage of single‐stranded nucleic acids

V. Vlassov, M. Podyminogin, I. V. Kutiavin, 1984 .

Sequence-specific interaction of pyrimidine oligonucleotides with double-stranded DNA at acidic pH complexes of different types

V. Vlassov, Y. Demchenko, E. Demchenko, 2009, Russian Journal of Bioorganic Chemistry.

Activation of spleen lymphocytes by plasmid DNA.

V. Vlassov, P. Laktionov, E. Rykova, 1999, Nucleosides & nucleotides.

Design, RNA cleavage and antiviral activity of new artificial ribonucleases derived from mono-, di- and tripeptides connected by linkers of different hydrophobicity.

V. Vlassov, M. Zenkova, V. Silnikov, 2016, Bioorganic & medicinal chemistry.

Exosomes in tears of healthy individuals: Isolation, identification, and characterization

V. Vlassov, P. Laktionov, Marsel R Kabilov, 2016, Biochemistry (Moscow) Supplement Series B: Biomedical Chemistry.

[Characteristics of exosomes andmicroparticles discovered in human tears].

V. Vlassov, P. Laktionov, A. Tupikin, 2016, Biomeditsinskaia khimiia.

Modified concatemeric oligonucleotide complexes: new system for efficient oligonucleotide transfer into mammalian cells.

V. Vlassov, M. Zenkova, Olesya N Gusachenko Simonova, 2008, Human gene therapy.

The Rossmann fold of glyceraldehyde-3-phosphate dehydrogenase (GAPDH) is a nuclear docking site for antisense oligonucleotides containing a TAAAT motif.

R. Kraft, V. Vlassov, P. Laktionov, 2001, Biochimica et biophysica acta.

Prooligonucleotides Exhibit Less Serum-Protein Binding Than Phosphodiester and Phosphorothioate Oligonucleotides

V. Vlassov, P. Laktionov, B. Rayner, 2000, Nucleosides, nucleotides & nucleic acids.

Bacteriophages as Therapeutic Preparations: What Restricts Their Application in Medicine

V. Vlassov, N. Tikunova, V. Morozova, 2020, Biochemistry (Moscow).

Selective protection of nuclease-sensitive sites in siRNA prolongs silencing effect.

V. Vlassov, A. Venyaminova, M. Zenkova, 2009, Oligonucleotides.

Purified horse milk exosomes contain an unpredictable small number of major proteins

V. Vlassov, P. Dmitrenok, E. Ryabchikova, 2017, Biochimie open.

Folate-Equipped Cationic Liposomes Deliver Anti-MDR1-siRNA to the Tumor and Increase the Efficiency of Chemotherapy

I. V. Chernikov, V. Vlassov, M. Zenkova, 2021, Pharmaceutics.

Synthesis and properties of photolabile (caged) phosphotriester derivatives of dinucleoside phosphates

V. Vlassov, B. Lebleu, J. Leonetti, 2000, Russian Journal of Bioorganic Chemistry.

Cleavage of RNA by Imidazole

V. Vlassov, A. Vlassov, 2004 .

Tertiary structure of tRNAs in solution monitored by phosphodiester modification with ethylnitrosourea.

V. Vlassov, J. Ebel, R. Giegé, 1981, European journal of biochemistry.

Interaction of Lipophilic Conjugates of Modified siRNAs with Hematopoietic Cells In Vitro and In Vivo

I. V. Chernikov, V. Vlassov, M. Zenkova, 2021, Russian Journal of Bioorganic Chemistry.

Cholesterol-conjugated Sirna Accumulates in the Different Hematopoietic and Lymphoid Cells.

I. V. Chernikov, V. Vlassov, A. Venyaminova, 2016 .

Single Shot vs. Cocktail: A Comparison of Mono- and Combinative Application of miRNA-Targeted Mesyl Oligonucleotides for Efficient Antitumor Therapy

V. Vlassov, D. Stetsenko, M. Zenkova, 2022, Cancers.

Protection of phosphodiester bonds in yeast tRNAVal by its cognate aminoacyl‐tRNA synthetase against alkylation by ethylnitrosourea

V. Vlassov, J. Ebel, R. Giegé, 1981, FEBS letters.

Blood deoxyribonuclease activity in health and diseases

V. Vlassov, P. Laktionov, S. Tamkovich, 2007, Biomeditsinskaia khimiia.

Sequence‐specific chemical modification of a 365‐nucleotide‐long DNA fragment with an alkylating oligonucleotide derivative

V. Vlassov, S. Gaidamakov, S. Grachev, 1985, FEBS letters.

Hybridization of Antisense Oligonucleotides with α‐Sarcin Loop Region of Escherichia coli 23S rRNA

V. Vlassov, V. Petyuk, M. Zenkova, 2004, Nucleosides, nucleotides & nucleic acids.

Trimeric Small Interfering RNAs and Their Cholesterol-Containing Conjugates Exhibit Improved Accumulation in Tumors, but Dramatically Reduced Silencing Activity

I. V. Chernikov, V. Vlassov, M. Meschaninova, 2020, Molecules.

Mesyl phosphoramidate backbone modified antisense oligonucleotides targeting miR-21 with enhanced in vivo therapeutic potency.

S. Altman, V. Vlassov, A. Fokina, 2020, Proceedings of the National Academy of Sciences of the United States of America.

Cell-Free miRNA-141 and miRNA-205 as Prostate Cancer Biomarkers.

V. Vlassov, P. Laktionov, I. Zaporozhchenko, 2016, Advances in experimental medicine and biology.

Iontophoretic delivery of oligonucleotide derivatives into mouse tumor.

V. Vlassov, L. Yakubov, M. Nechaeva, 1994, Antisense research and development.

Isolation and Sequencing of Short Cell‐Surface‐Bound DNA

V. Vlassov, P. Laktionov, A. Bondar, 2008, Annals of the New York Academy of Sciences.

2'OMe Modification of Anti-miRNA-21 Oligonucleotide–Peptide Conjugate Improves Its Hybridization Properties and Catalytic Activity

V. Vlassov, M. Zenkova, O. Patutina, 2019, Russian Journal of Bioorganic Chemistry.

Interaction of cholesterol‐conjugated alkylating oligonucleotide derivatives with cellular biopolymers

V. Vlassov, E. Ivanova, E. Ivanova, 1992, FEBS letters.

INTERACTION OF LNA OLIGONUCLEOTIDES WITH MDR1 PROMOTER

V. Vlassov, E. Chernolovskaya, A. Koshkin, 2001, Nucleosides, nucleotides & nucleic acids.

Enhanced cellular binding of concatemeric oligonucleotide complexes.

V. Vlassov, M. Zenkova, O. Simonova, 2006, Biochimica et biophysica acta.

Isolation of Nucleic Acid Binding Proteins: An Approach for Isolation of Cell Surface, Nucleic Acid Binding Proteins

V. Vlassov, B. Chelobanov, P. Laktionov, 2004, Annals of the New York Academy of Sciences.

Reactive oligonucleotide derivatives as gene-targeted biologically active compounds and affinity probes

V. Vlassov, D. G. Knorre, 2004, Genetica.

Penetration of oligonucleotides into mouse organism through mucosa and skin

V. Vlassov, L. Yakubov, V. Karamyshev, 1993, FEBS letters.

Cell membranes as barriers for antisense constructions.

V. Vlassov, V. Budker, D. G. Knorre, 1992, Antisense research and development.

Nucleotide and oligonucleotide derivatives as enzyme and nucleic acid targeted irreversible inhibitors. Biochemical aspects.

V. Vlassov, L. Yurchenko, A. Bukrinskaya, 1985, Advances in enzyme regulation.

Fluorometric quantification of RNA and DNA in solutions containing both nucleic acids.

V. Vlassov, P. Laktionov, E. Rykova, 2003, Analytical biochemistry.

Circulating DNA and DNase Activity in Human Blood

D. Pyshnyi, V. Vlassov, P. Laktionov, 2006, Annals of the New York Academy of Sciences.

The effect of modification of terminal groups of oligonucleotides on their stability in mycoplasma culture

V. Vlassov, E. Ivanova, V. Zarytova, 1991 .

Gene-targeted inhibition of transactivation of human immunodeficiency virus type-1 (HIV-1)-LTR by antisense oligonucleotides

V. Vlassov, P. Chandra, F. Svinarchuk, 2005, Virus Genes.

Fluorophore Labeling Affects the Cellular Accumulation and Gene Silencing Activity of Cholesterol-Modified siRNAs In Vitro.

I. V. Chernikov, V. Vlassov, M. Zenkova, 2019, Nucleic acid therapeutics.

Visible Light Activatable Binary System of Oligonucleotide Conjugates for Nucleic Acids Modification

V. Vlassov, M. Dobrikov, T. I. Gainutdinov, 1999 .

Sensitized photomodification of single-stranded DNA by a binary system of oligonucleotide conjugates.

V. Vlassov, A. Koshkin, S. Gaidamakov, 1997, Antisense & nucleic acid drug development.

Design and Targeted Reactions of Oligonucleotide Derivatives

V. Vlassov, V. Zarytova, D. G. Knorre, 1993 .

Blood Based Methylated DNA and Tumor-Specific Protein Analysis in Gastric Cancer Diagnostics

V. Vlassov, E. Chikova, P. Laktionov, 2010 .

Circulating DNA in the Blood of Gastric Cancer Patients

V. Vlassov, P. Laktionov, E. Rykova, 2008, Annals of the New York Academy of Sciences.

Impact of chemical modifications in the structure of isRNA on its antiproliferative and immunostimulatory properties

V. Vlassov, M. Zenkova, M. Meschaninova, 2017, Russian Journal of Bioorganic Chemistry.

Immunostimulating RNA Delivered by P1500 PEGylated Cationic Liposomes Limits Influenza Infection in C57Bl/6 Mice

V. Vlassov, M. Zenkova, E. Chernolovskaya, 2020, Pharmaceutics.

Knock down of cytosolic phospholipase A2: an antisense oligonucleotide having a nuclear localization binds a C-terminal motif of glyceraldehyde-3-phosphate dehydrogenase.

V. Vlassov, P. Laktionov, E. Spisni, 2004, Biochimica et biophysica acta.

Binary Hammerhead Ribozymes with High Cleavage Activity

V. Vlassov, A. Venyaminova, M. Repkova, 2004, Nucleosides, nucleotides & nucleic acids.

Catalytic DNA and RNA for Targeting MDR1 mRNA

V. Vlassov, A. Venyaminova, M. Lukin, 2003, Nucleosides, nucleotides & nucleic acids.

Circulating microRNAs in lung cancer: Prospects for diagnosis, prognosis, and prediction of antitumor treatment efficacy

V. Vlassov, P. Laktionov, E. Rykova, 2015, Molecular Biology.

siRNA-Mediated Timp1 Silencing Inhibited the Inflammatory Phenotype during Acute Lung Injury

I. V. Chernikov, V. Vlassov, E. Chernolovskaya, 2023, International journal of molecular sciences.

Cleavage of yeast tRNAPhe with complementary oligonucleotide conjugated to a small ribonuclease mimic

V. Vlassov, M. Zenkova, N. Beloglazova, 2000, FEBS letters.

Sequence-specific cleavage of yeast tRNA(Phe) with oligonucleotides conjugated to a diimidazole construct.

V. Vlassov, R. Giegé, V. Silnikov, 1997, Antisense & nucleic acid drug development.

Synthesis and Pro-Apoptotic Activity of Novel Glycyrrhetinic Acid Derivatives

V. Vlassov, M. Zenkova, N. Salakhutdinov, 2011, Chembiochem : a European journal of chemical biology.

RNA bulges as targets for selective cleavage by metal ions and organic compounds

V. Vlassov, M. Zenkova, I. Kuznetsova, 2007 .

Enhanced RNA cleavage within bulge-loops by an artificial ribonuclease

V. Vlassov, H. Gross, M. Zenkova, 2005, Nucleic acids research.

Cleavage of RNA with synthetic ribonuclease mimics.

B. Felden, V. Vlassov, R. Giegé, 2000, Methods in enzymology.

Synthesis and Characterization of Artificial Ribonucleases

V. Vlassov, R. Giegé, M. Zenkova, 1999 .

Mechanism and specificity of RNA cleavage by chemical ribonucleases.

V. Vlassov, R. Giegé, M. Zenkova, 1999, Nucleosides & nucleotides.

ARTIFICIAL RIBONUCLEASES : SYNTHESIS AND RNA CLEAVING PROPERTIES OF CATIONIC CONJUGATES BEARING IMIDAZOLE RESIDUES

V. Vlassov, M. Zenkova, V. Silnikov, 1999 .

Synthetic RNA-cleaving molecules mimicking ribonuclease A active center. Design and cleavage of tRNA transcripts.

V. Vlassov, R. Giegé, M. Podyminogin, 1993, Nucleic acids research.

Novel cholesterol spermine conjugates provide efficient cellular delivery of plasmid DNA and small interfering RNA.

V. Vlassov, M. Zenkova, G. A. Serebrennikova, 2012, Journal of controlled release : official journal of the Controlled Release Society.

'Dual' peptidyl-oligonucleotide conjugates: Role of conformational flexibility in catalytic cleavage of RNA.

V. Vlassov, M. Zenkova, Kepa K. Burusco, 2017, Biomaterials.

Oligonucleotides: Superspecific Ligands for Targeting Nucleic Acids and Proteins and Development of Molecular Devices

V. Vlassov, 2007 .

Mesyl phosphoramidate antisense oligonucleotides as an alternative to phosphorothioates with improved biochemical and biological properties

S. Altman, V. Vlassov, A. Fokina, 2019, Proceedings of the National Academy of Sciences.

Artificial ribonucleases: from combinatorial libraries to efficient catalysts of RNA cleavage.

V. Vlassov, M. Zenkova, V. Silnikov, 2006, Bioorganic chemistry.

Structure-activity relationships in new polycationic molecules based on two 1,4-diazabicyclo[2.2.2]octanes as artificial ribonucleases.

V. Vlassov, M. Zenkova, V. Silnikov, 2014, Bioorganic chemistry.

Complementary addressed modification of oligonucleotide d(pGpGpCpGpGpA) with platinum derivative of oligonucleotide d(pTpCpCpGpCpCpTpTpT)

V. Vlassov, S. Kazakov, E. Ivanova, 1983 .

Non-enzymatic recombination of RNA: Ligation in loops.

V. Vlassov, R. Bryce, M. Zenkova, 2017, Biochimica et biophysica acta. General subjects.

Cleavage of RNA bulge loops by artificial RNases

V. Vlassov, M. Zenkova, I. Kuznetsova, 2006 .

Inactivation of a non-enveloped RNA virus by artificial ribonucleases: honey bees and acute bee paralysis virus as a new experimental model for in vivo antiviral activity assessment.

J. Tautz, V. Vlassov, H. Gross, 2011, Antiviral research.

Complementary-addressed (sequence-specific) modification of nucleic acids.

V. Vlassov, D. G. Knorre, D. Knorre, 1985, Progress in nucleic acid research and molecular biology.

DNA inhibits dsRNA-induced secretion of pro-inflammatory cytokines by gingival fibroblasts.

V. Vlassov, P. Laktionov, M. Kharkova, 2013, Immunobiology.

The enhancin gene: One of the genetic determinants of population variation in baculoviral virulence

J. D. Podgwaite, V. Vlassov, O. Baturina, 2015, Doklady Biochemistry and Biophysics.

Oligonucleotides and polynucleotides as biologically active compounds.

V. Vlassov, I. Vlassova, L. Pautova, 1997, Progress in nucleic acid research and molecular biology.

Immunochemical and molecular-Genetic markers in diagnostics of gastric cancer

V. Vlassov, P. Laktionov, E. Rykova, 2009 .

Inactivation of the tick-borne encephalitis virus by RNA-cleaving compounds

V. Vlassov, M. Zenkova, V. Silnikov, 2011, Journal of molecular and genetic medicine : an international journal of biomedical research.

Structural flexibility of a DNA hairpin located in the long terminal repeat of the Drosophila 1731 retrotransposon.

V. Vlassov, Y. Demchenko, A Slama-Schwok, 1998, Nucleic acids research.

Specificity of interaction of pyrimidine oligonucleotides with DNA at acidic pH in the presence of magnesium ions: affinity modification study.

V. Vlassov, E. Demchenko, E. Brossalina, 1993, Antisense research and development.

Complementary addressed modification of nucleic acids with the alkylating derivatives of oligothymidylate ethyl phosphotriesters Effect of the phosphotriester fragments' configuration

V. Vlassov, A. V. Lebedev, T.V. Abramova, 1988, FEBS letters.

Ethidium Oligodeoxynucleotide Derivatives. Stability Against Cellular Nuclease Hydrolysis and Photochemical Modification of Cellular Proteins in the Living Cells

V. Vlassov, A. Koshkin, A. V. Lebedev, 1991 .

Dual miRNases for Triple Incision of miRNA Target: Design Concept and Catalytic Performance

V. Vlassov, M. Zenkova, N. Mironova, 2020, Molecules.

Cleavage of Leishmania Mini-exon Sequence by Oligonucleotides Conjugated to a Dimidazole Construction

J. Toulmé, V. Vlassov, V. Silnikov, 1997 .

c-fos protooncogene transcription can be modulated by oligonucleotide-mediated formation of triplex structures in vitro.

V. Vlassov, N. Abraham, Y. Lavrovsky, 1996, European journal of biochemistry.

Downregulation of PGY1/MDR1 mRNA level in human KB cells by antisense oligonucleotide conjugates. RNA accessibility in vitro and intracellular antisense activity.

V. Vlassov, M. Zenkova, P. Laktionov, 2002, Biochimica et biophysica acta.

The Effect of Oligodeoxyribonucleotide Terminal Phosphate and Ribose Modification on the Interactions of Oligonucleotides with Cells and Intracellular Stability

V. Vlassov, E. Ivanova, V. Zarytova, 1991 .

Synthesis of alkylating oligonucleotide derivatives containing cholesterol or phenazinium residues at their 3′‐terminus and their interaction with DNA within mammalian cells

V. Vlassov, L. Yurchenko, E. Ivanova, 1989, FEBS letters.

Site-Selective Artificial Ribonucleases: Oligonucleotide Conjugates Containing Multiple Imidazole Residues in the Catalytic Domain

V. Vlassov, N. Polushin, M. Zenkova, 2011, Journal of nucleic acids.

Suppression of Transcription and Translation of the Influenza Virus RNAs by Oligonucleotide Derivatives

V. Vlassov, E. Frolova, G. Nevinsky, 1991 .

Sequence-specific artificial ribonucleases. I. Bis-imidazole-containing oligonucleotide conjugates prepared using precursor-based strategy.

V. Vlassov, N. Polushin, K. Douglas, 2004, Nucleic acids research.

Refined high-field NMR solution structure of a binary-addressed pyrene/perfluoro-azide complementary DNA oligonucleotide system shows extensive distortion in the central nick region.

D. Marks, V. Vlassov, K. Douglas, 1999, Journal of biomolecular structure & dynamics.

Surveillance of Tumour Development: The Relationship Between Tumour-Associated RNAs and Ribonucleases

V. Vlassov, N. Mironova, 2019, Front. Pharmacol..

Inhibition of HIV proliferation in MT-4 cells by antisense oligonucleotide conjugated to lipophilic groups.

V. Vlassov, F. Svinarchuk, A. Pokrovsky, 1993, Biochimie.

Perfluoroarylazide Derivatives of 2′-O-Modified Oligoribonucleotides: Efficient Reagents for RNA Photomodification

V. Vlassov, A. Venyaminova, M. Zenkova, 2005, Nucleosides, nucleotides & nucleic acids.

Non-Enzymatic Template-Directed Recombination of RNAs

V. Vlassov, M. Zenkova, Sergey Y. Nechaev, 2009, International journal of molecular sciences.

Equilibrium screening‐dialysis investigation of the nucleotide sequences in the tRNAPhe recognized by phenylalanyl‐tRNA synthetase (escherichia coli)

V. Vlassov, S. Khodyreva, S.N. Khodyreva, 1978, FEBS letters.

Transport Oligonucleotides—A Novel System for Intracellular Delivery of Antisense Therapeutics

I. V. Chernikov, D. Pyshnyi, V. Vlassov, 2020, Molecules.

Invasion of Strongly Binding Oligonucleotides into tRNA Structure

V. Vlassov, R. Giegé, V. Petyuk, 2000, Nucleosides, nucleotides & nucleic acids.

Antisense oligonucleotides inhibiting ribosomal functions in mycobacteria

V. Vlassov, M. Zenkova, Y. Demchenko, 2005, Biology Bulletin.

Reversion of the multiple-drug resistance phenotype mediated by short interfering RNAs

A. N. Zenkov, V. Vlassov, E. Chernolovskaya, 2005 .

5′-BIS-PYRENYLATED OLIGONUCLEOTIDES DISPLAY ENHANCED EXCIMER FLUORESCENCE UPON HYBRIDIZATION WITH DNA AND RNA

V. Vlassov, M. Zenkova, N. Komarova, 2001, Nucleosides, nucleotides & nucleic acids.

Secondary structure of the 5′‐region of PGY1/MDR1 mRNA

V. Vlassov, M. Zenkova, E. Kostenko, 2000, FEBS letters.

Cleavage of RNA by an amphiphilic compound lacking traditional catalytic groups.

V. Vlassov, M. Zenkova, N. Kovalev, 2008, Bioorganic chemistry.

Ribonuclease Activity of Cationic Structures Conjugated to Lipophilic Groups

V. Vlassov, M. Zenkova, E. Burakova, 2004, Nucleosides, nucleotides & nucleic acids.

The Role of Hydrophobic Interactions in Catalysis of RNA Cleavage by 1,4‐Diazabicyclo[2.2.2]‐Octane Based Artificial Ribonucleases

V. Vlassov, M. Zenkova, F. Tuzikov, 2004, Nucleosides, nucleotides & nucleic acids.

Modulation of the Antiviral 2-5A System in Human Immunodeficiency Virus-1-Infected CEM Cells by Propentofylline

V. Vlassov, M. Kelve, A. Kuusksalu, 1996 .

Inhibition of human carcinoma and neuroblastoma cell proliferation by anti-c-myc siRNA.

V. Vlassov, E. Chernolovskaya, T. Kabilova, 2006, Oligonucleotides.

Catalytic Knockdown of miR-21 by Artificial Ribonuclease: Biological Performance in Tumor Model

V. Vlassov, M. Zenkova, N. Mironova, 2019, Front. Pharmacol..

Design of site-specific RNA-cleaving reagents

V. Vlassov, V. Silnikov, 2001 .

Serum immunoglobulins interact with oligonucleotides

V. Vlassov, E. Rykova, L. Yakubov, 1994, FEBS letters.

Activation of spleen lymphocytes by plasmid DNA.

V. Vlassov, P. Laktionov, E. Rykova, 1999, Vaccine.

Sequence-specific alkylation of dsDNA with derivatives of pyrimidine oligonucleotides conjugated to 2-chloroethylamine groups.

V. Vlassov, S. Mamaev, E. Demchenko, 1991, Antisense research and development.

Interaction of tRNAPhe and tRNAVal with aminoacyl-tRNA synthetases. A chemical modification study.

V. Vlassov, J. Ebel, R. Giegé, 1983, European journal of biochemistry.

Current Development of siRNA Bioconjugates: From Research to the Clinic

I. V. Chernikov, V. Vlassov, E. Chernolovskaya, 2019, Front. Pharmacol..

42‐ and 63‐bp anti‐MDR1‐siRNAs bearing 2′‐OMe modifications in nuclease‐sensitive sites induce specific and potent gene silencing

V. Vlassov, A. Venyaminova, M. Zenkova, 2014, FEBS letters.

Nucleic Acids: Structures, Functions, and Applications

D. Pyshnyi, V. Vlassov, P. Vorobjev, 2009 .

MicroRNA Drop in the Bloodstream and MicroRNA Boost in the Tumour Caused by Treatment with Ribonuclease A Leads to an Attenuation of Tumour Malignancy

A. Kurilshikov, V. Vlassov, M. Zenkova, 2013, PloS one.

The systemic tumor response to RNase A treatment affects the expression of genes involved in maintaining cell malignancy

A. Kurilshikov, V. Vlassov, M. Zenkova, 2017, Oncotarget.

Inhibition of metastasis development by daily administration of ultralow doses of RNase A and DNase I.

V. Vlassov, M. Zenkova, E. Ryabchikova, 2011, Biochimie.

Inhibition of human cancer-cell proliferation by long double-stranded RNAs.

V. Vlassov, E. Chernolovskaya, T. Kabilova, 2009, Oligonucleotides.

Protective Allele for Multiple Sclerosis HLA-DRB1*01:01 Provides Kinetic Discrimination of Myelin and Exogenous Antigenic Peptides

Alexander V. Favorov, V. Vlassov, O. Favorova, 2020, Frontiers in Immunology.

Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H

D. Pyshnyi, V. Vlassov, M. A. Bazhenov, 2018, Scientific Reports.

Circulating DNA-based lung cancer diagnostics and follow-up: looking for epigenetic markers

V. Vlassov, P. Laktionov, E. Rykova, 2018 .

Whole-Genome DNA Methylation Analysis of Peripheral Blood Mononuclear Cells in Multiple Sclerosis Patients with Different Disease Courses

V. Vlassov, O. Favorova, N. Baulina, 2016, Acta naturae.

Analysis of peptides and small proteins in preparations of horse milk exosomes, purified on anti-CD81-Sepharose

V. Vlassov, P. Dmitrenok, E. Ryabchikova, 2021 .

Human gut microbiota community structures in urban and rural populations in Russia

Dmitry G. Alexeev, Elena S. Kostryukova, Alexander V. Tyakht, 2013, Nature Communications.

Deoxyribonuclease Activity and Circulating DNA Concentration in Blood Plasma of Patients with Prostate Tumors

V. Vlassov, P. Laktionov, Pavel P Laktionov, 2008, Annals of the New York Academy of Sciences.

Chemical and Computer Probing of RNA Structure1

N. A. Kolchanov, V. Vlassov, I. Titov, 1996, Progress in Nucleic Acid Research and Molecular Biology.

Silencing activity of 2′‐O‐methyl modified anti‐MDR1 siRNAs with mismatches in the central part of the duplexes

V. Vlassov, A. Venyaminova, M. Zenkova, 2011, FEBS letters.

Silencing of MDR 1 Gene in Cancer Cells by siRNA

V. Vlassov, A. Venyaminova, E. Chernolovskaya, 2004, Nucleosides, nucleotides & nucleic acids.

Investigation of the Internalization of Fluorescently Labeled Lipophilic siRNA into Cultured Tumor Cells

I. V. Chernikov, V. Vlassov, M. Zenkova, 2019, Russian Journal of Bioorganic Chemistry.

Uptake of oligonucleotide alkylating derivatives by the cells in the presence of substances stimulating transfection

V. Vlassov, L. Yurchenko, E. Ivanova, 1989 .

Antiproliferative and interferon-inducing activities of unique short double-stranded RNA

V. Vlassov, M. Zenkova, E. Chernolovskaya, 2011, Doklady Biochemistry and Biophysics.

Nuclease‐resistant 63‐bp trimeric siRNAs simultaneously silence three different genes in tumor cells

I. V. Chernikov, V. Vlassov, A. Venyaminova, 2018, FEBS Letters.

The efficient method for DNA encapsulation into reconstituted sendai virus envelopes

V. Vlassov, V. Repin, F. Svinarchuk, 1988 .

Novel cholesterol-based cationic lipids for gene delivery.

V. Vlassov, M. Zenkova, M. Maslov, 2009, Journal of medicinal chemistry.

Arrest of Cancer Cell Proliferation by dsRNAs

V. Vlassov, E. Chernolovskaya, A. V. Vladimirova, 2006, Annals of the New York Academy of Sciences.

Suppression of MDR1 gene expression by chemically modified siRNAs

V. Vlassov, M. Zenkova, E. Chernolovskaya, 2006 .

Silencing of c‐myc Expression in Tumor Cells by siRNA

V. Vlassov, E. Chernolovskaya, T. Kabilova, 2004, Nucleosides, nucleotides & nucleic acids.

Modified siRNA effectively silence inducible immunoproteasome subunits in NSO cells.

V. Vlassov, A. Venyaminova, M. Zenkova, 2016, Biochimie.

Mechanism of Antisense Oligonucleotide Interaction with Natural RNAs

V. Vlassov, V. Petyuk, M. Zenkova, 2011, Journal of biomolecular structure & dynamics.

The siRNA targeted to mdr1b and mdr1a mRNAs in vivo sensitizes murine lymphosarcoma to chemotherapy

V. Vlassov, M. Zenkova, O. Patutina, 2010, BMC Cancer.

2'-O-methyl-modified anti-MDR1 fork-siRNA duplexes exhibiting high nuclease resistance and prolonged silencing activity.

V. Vlassov, A. Venyaminova, M. Zenkova, 2010, Oligonucleotides.

Circulating Nucleic Acids in Health and Disease

V. Vlassov, P. Laktionov, E. Rykova, 2010 .

2′-MODIFIED OLIGONUCLEOTIDES FROM METHOXYOXALAMIDO AND SUCCINIMIDO PRECURSORS: SYNTHESIS, PROPERTIES, AND APPLICATIONS

V. Vlassov, A. Malykh, N. Polushin, 2001, Nucleosides, nucleotides & nucleic acids.

RNA World: First Steps Towards Functional Molecules

V. Vlassov, M. Zenkova, A. Lutay, 2008 .

Extracellular nucleic acids

V. Vlassov, P. Laktionov, E. Rykova, 2007, BioEssays : news and reviews in molecular, cellular and developmental biology.

What information can be obtained from the tears of a patient with primary open angle glaucoma?

V. Vlassov, A. Tupikin, E. Ryabchikova, 2019, Clinica chimica acta; international journal of clinical chemistry.

Profiling of 179 miRNA Expression in Blood Plasma of Lung Cancer Patients and Cancer-Free Individuals

V. Vlassov, P. Laktionov, E. Rykova, 2018, Scientific Reports.

Rapid sequence‐independent cellular response to oligodeoxynucleotides

V. Vlassov, J. Chroboczek, L. Balakireva, 1997, FEBS letters.

Heavy-light chain interrelations of MS-associated immunoglobulins probed by deep sequencing and rational variation.

Alexander V. Favorov, V. Vlassov, Y. Medvedeva, 2014, Molecular immunology.

Ku protein as the main cellular target of cell-surface-bound circulating DNA

V. Vlassov, P. Laktionov, I. Zaporozhchenko, 2012, Expert opinion on biological therapy.

Potentialities of aberrantly methylated circulating DNA for diagnostics and post-treatment follow-up of lung cancer patients.

L. Bryzgalov, V. Vlassov, P. Laktionov, 2013, Lung cancer.

A comparative study of cell-free apoptotic and genomic DNA using FISH and massive parallel sequencing

A. Kurilshikov, V. Vlassov, P. Laktionov, 2012, Expert opinion on biological therapy.

Cell-free and cell-bound circulating nucleic acid complexes: mechanisms of generation, concentration and content

V. Vlassov, P. Laktionov, E. Rykova, 2012, Expert opinion on biological therapy.

Molecular genetic markers in diagnosis of lung cancer

V. Vlassov, P. Laktionov, E. Rykova, 2011, Molecular Biology.

Deoxyribonuclease activity in biological fluids of healthy donors and cancer patients

V. Vlassov, P. Laktionov, O. Bryzgunova, 2008, Bulletin of Experimental Biology and Medicine.

The Effect of Protein Transport Inhibitors on the Production of Extracellular DNA

V. Vlassov, P. Laktionov, T. I. Babochkina, 2008, Annals of the New York Academy of Sciences.

Methylation‐Specific Sequencing of GSTP1 Gene Promoter in Circulating/Extracellular DNA from Blood and Urine of Healthy Donors and Prostate Cancer Patients

V. Vlassov, P. Laktionov, O. Bryzgunova, 2008, Annals of the New York Academy of Sciences.

Circulating nucleic acids in blood of healthy male and female donors.

V. Vlassov, P. Laktionov, E. Rykova, 2005, Clinical chemistry.

Release of Nucleic Acids by Eukaryotic Cells in Tissue Culture

V. Vlassov, P. Laktionov, E. Rykova, 2004, Nucleosides, nucleotides & nucleic acids.

Extracellular Nucleic Acids in Cultures of Long‐Term Cultivated Eukaryotic Cells

V. Vlassov, P. Laktionov, E. Rykova, 2004, Annals of the New York Academy of Sciences.

Dynamic changes in circulating miRNA levels in response to antitumor therapy of lung cancer

V. Vlassov, P. Laktionov, E. Rykova, 2016, Experimental lung research.

Circulating DNA in rheumatoid arthritis: pathological changes and association with clinically used serological markers

L. Bryzgalov, V. Vlassov, P. Laktionov, 2017, Arthritis Research & Therapy.

Hypomethylation of human-specific family of LINE-1 retrotransposons in circulating DNA of lung cancer patients.

V. Vlassov, P. Laktionov, E. Rykova, 2016, Lung cancer.

Efficacy of Bisulfite Modification and DNA Recovery Using Commercial Kits from Samples of Genomic and Circulating DNA

V. Vlassov, K. Miller, P. Laktionov, 2013 .

A reliable method to concentrate circulating DNA.

V. Vlassov, P. Laktionov, O. Bryzgunova, 2011, Analytical biochemistry.

Chapter 25 Methylated Cell-Free DNA In Vitro and In Vivo

V. Vlassov, P. Laktionov, O. Bryzgunova, 2010 .

Methylated Cell-Free DNA In Vitro and In Vivo

V. Vlassov, P. Laktionov, O. Bryzgunova, 2010 .

Breast cancer diagnostics based on extracellular DNA and RNA circulating in blood

A. V. Starikov, V. Vlassov, G. Sczakiel, 2008, Biomeditsinskaia khimiia.

Immunochemical assay for deoxyribonuclease activity in body fluids.

D. Pyshnyi, V. Vlassov, P. Laktionov, 2007, Journal of immunological methods.

Extracellular Circulating Nucleic Acids in Human Plasma in Health and Disease

A. V. Starikov, S. V. Sumarokov, V. Vlassov, 2004, Nucleosides, nucleotides & nucleic acids.

Extracellular Ribonucleic Acids of Human Milk

V. Vlassov, D. Semenov, V. Richter, 2004, Annals of the New York Academy of Sciences.

The Core of Gut Life: Firmicutes Profile in Patients with Relapsing-Remitting Multiple Sclerosis

V. Vlassov, M. Kabilov, A. Boyko, 2021, Life.

Multicomponent mannose-containing liposomes efficiently deliver RNA in murine immature dendritic cells and provide productive anti-tumour response in murine melanoma model.

V. Vlassov, M. Zenkova, M. Maslov, 2015, Journal of controlled release : official journal of the Controlled Release Society.

Epigenetic probes for lung cancer monitoring: Line-1 methylation pattern in blood-circulating DNA

L. Bryzgalov, T. Merkulova, V. Vlassov, 2016, Russian Journal of Genetics: Applied Research.

Oligo(A), oligo(TG), and Alu repeats of DNA in chromatin are available for sequence-specific chemical modification with oligodeoxynucleotide derivatives.

V. Vlassov, E. Chernolovskaya, R. Borissov, 1994, Antisense research and development.

Affinity modification of human chromatin with reactive derivatives of oligonucleotides

V. Vlassov, E. Chernolovskaya, R. Borissov, 1992, FEBS letters.

Novel cationic liposomes provide highly efficient delivery of DNA and RNA into dendritic cell progenitors and their immature offsets.

V. Vlassov, M. Zenkova, M. Maslov, 2012, Journal of controlled release : official journal of the Controlled Release Society.

Extracellular DNA in Culture of Primary and Transformed Cells, Infected and Not Infected with Mycoplasma

V. Vlassov, P. Laktionov, E. Rykova, 2009, Bulletin of experimental biology and medicine.

Influence of Mycoplasma Contamination on the Concentration and Composition of Extracellular RNA

V. Vlassov, P. Laktionov, E. Rykova, 2006, Annals of the New York Academy of Sciences.

A Method for Generating Selective DNA Probes for the Analysis of C-Negative Regions in Human Chromosomes

V. Vlassov, V. Babenko, P. Laktionov, 2011, Cytogenetic and Genome Research.

Short double-stranded RNA with immunostimulatory activity: sequence dependence.

V. Vlassov, A. Venyaminova, M. Zenkova, 2012, Nucleic acid therapeutics.

Novel PEGylated Liposomes Enhance Immunostimulating Activity of isRNA

V. Vlassov, M. Zenkova, M. Maslov, 2018, Molecules.

Antitumor and Antimetastatic Effect of Small Immunostimulatory RNA against B16 Melanoma in Mice

V. Vlassov, M. Zenkova, E. Chernolovskaya, 2016, PloS one.

Silencing of Inducible Immunoproteasome Subunit Expression by Chemically Modified siRNA and shRNA

V. Prassolov, V. Vlassov, M. Zenkova, 2016, Nucleosides, nucleotides & nucleic acids.

Trans Hammerhead Ribozyme: Ligation vs. Cleavage

M. Vorobjeva, V. Vlassov, A. Venyaminova, 2008 .

Interaction of Keratin K1 with Nucleic Acids on the Cell Surface

D. Pyshnyi, V. Vlassov, B. Chelobanov, 2003, Biochemistry (Moscow).

G-specific RNA-cleaving Conjugates of Short Peptides and Oligodeoxyribonucleotides

D. Pyshnyi, V. Vlassov, H. Gross, 2006, Journal of biomolecular structure & dynamics.

Downregulation of activated leukemic oncogenes AML1-ETO and RUNX1(K83N) expression with RNA-interference

V. Prassolov, V. Vlassov, C. Stocking, 2010, Molecular Biology.

Nucleic acids in exosomes: Disease markers and intercellular communication molecules

V. Vlassov, M. Zenkova, O. Gusachenko, 2013, Biochemistry (Moscow).

Nucleic acids in exosomes: Disease markers and intercellular communication molecules

V. Vlassov, M. Zenkova, V. V. Vlassov, 2013, Biochemistry (Moscow).

Extra Purified Exosomes from Human Placenta Contain an Unpredictable Small Number of Different Major Proteins

V. Vlassov, P. Dmitrenok, E. Ryabchikova, 2019, International journal of molecular sciences.

Exosomes from human placenta purified by affinity chromatography on sepharose bearing immobilized antibodies against CD81 tetraspanin contain many peptides and small proteins

V. Vlassov, P. Dmitrenok, E. Ryabchikova, 2018, IUBMB life.

Oligodeoxynucleotides interact with recombinant CD4 at multiple sites.

V. Vlassov, L. Yakubov, A. Truneh, 1993, The Journal of biological chemistry.

Complete Genome Sequence of the Novel Giant Pseudomonas Phage PaBG

V. Vlassov, M. Shneider, L. Kurochkina, 2014, Genome Announcements.

Applications of Bacteriophages in the Treatment of Localized Infections in Humans

V. Vlassov, N. Tikunova, V. Morozova, 2018, Front. Microbiol..

Modern methods of prostate cancer diagnostics

V. Vlassov, P. Laktionov, O. Bryzgunova, 2007, Biomeditsinskaia khimiia.

Sequence‐specific chemical modification of a hybrid bacteriophage M 13 single‐stranded DNA by alkylating oligonucleotide derivatives

V. Vlassov, V. Zarytova, S. Mamaev, 1988, FEBS letters.

Interaction of alkylating oligonucleotide derivatives with mouse fibroblasts

V. Vlassov, L. Yurchenko, E. Ivanova, 1986 .

Protocol for miRNA isolation from biofluids.

V. Vlassov, P. Laktionov, I. Zaporozhchenko, 2016, Analytical biochemistry.

RNase T1 mimicking artificial ribonuclease

D. Pyshnyi, V. Vlassov, M. Zenkova, 2007, Nucleic acids research.

Structural and dynamic aspects of recognition between tRNAs and aminoacyl-tRNA synthetases.

V. Vlassov, D. G. Knorre, D. Knorre, 1980, Molecular biology, biochemistry, and biophysics.

Concentrations of Circulating RNA from Healthy Donors and Cancer Patients Estimated by Different Methods

V. Vlassov, G. Sczakiel, P. Laktionov, 2006, Annals of the New York Academy of Sciences.

Extracellular Vesicles for Therapeutic Nucleic Acid Delivery: Loading Strategies and Challenges

V. Vlassov, M. Zenkova, A. Oshchepkova, 2023, International journal of molecular sciences.

Simple and rapid procedure suitable for quantitative isolation of low and high molecular weight extracellular nucleic acids.

V. Vlassov, P. Laktionov, E. Rykova, 2004, Nucleosides, nucleotides & nucleic acids.

Human Gut Microbiome Response to Short-Term Bifidobacterium-Based Probiotic Treatment

V. Vlassov, A. Tupikin, M. Kabilov, 2020, Indian Journal of Microbiology.

A New Y Chromosome Marker for Noninvasive Fetal Gender Determination

V. Vlassov, P. Laktionov, A. Katokhin, 2008, Annals of the New York Academy of Sciences.

Dynamics of LINE-1 retrotransposon methylation levels in circulating DNA from lung cancer patients undergoing antitumor therapy

V. Vlassov, P. Laktionov, E. Rykova, 2017, Molecular Biology.

Blood Circulating Exosomes Contain Distinguishable Fractions of Free and Cell-Surface-Associated Vesicles.

V. Vlassov, V. Tkachuk, P. Laktionov, 2019, Current molecular medicine.

Lytic bacteriophage PM16 specific for Proteus mirabilis: a novel member of the genus Phikmvvirus

A. Kurilshikov, V. Vlassov, N. Tikunova, 2016, Archives of Virology.

Primary progressive multiple sclerosis in a Russian cohort: relationship with gut bacterial diversity

V. Vlassov, Marsel R Kabilov, A. Boyko, 2019, BMC Microbiology.

Circulating nucleic acids as a potential source for cancer biomarkers.

V. Vlassov, P. Laktionov, E. Rykova, 2010, Current molecular medicine.

Structure-transfection activity relationships in a series of novel cationic lipids with heterocyclic head-groups.

V. Vlassov, M. Zenkova, G. A. Serebrennikova, 2013, Organic & biomolecular chemistry.

Impact of chemical modifications in the structure of isRNA on its antiproliferative and immunostimulatory properties

V. Vlassov, A. Venyaminova, M. Zenkova, 2017, Russian Journal of Bioorganic Chemistry.

Synthesis and transfection activity of novel galactosylated polycationic lipid.

V. Vlassov, M. Zenkova, G. A. Serebrennikova, 2011, Bioorganic & medicinal chemistry letters.

Investigation of surface oligonucleotide-binding proteins of eucaryotic cells by affinity modification with reactive oligonucleotide derivatives

D. Pyshnyi, V. Vlassov, B. Chelobanov, 2002 .

Comparative Study of Extracellular DNA by FISH

V. Vlassov, P. Laktionov, K. Zadesenets, 2010 .

Extracellular DNA in Breast Cancer: Cell‐Surface‐Bound, Tumor‐Derived Extracellular DNA in Blood of Patients with Breast Cancer and Nonmalignant Tumors

A. V. Starikov, V. Vlassov, P. Laktionov, 2004, Annals of the New York Academy of Sciences.

Acridine-based macrocycles as potential probes for studies of the structures of nucleic acids

V. Vlassov, M. Zenkova, Y. Demchenko, 2002 .

10-23 DNA enzymes for targeting MDR1 mRNA

V. Vlassov, A. Venyaminova, M. Repkova, 2002 .

Alkylation of tRNATrp in a complex with tryptophanyl‐tRNA synthetase

V. Vlassov, V.E. Tchizhikov, 1978, FEBS letters.

Expression of the MDR1 and MRP Genes in Patients with Lymphoma with Primary Bone Marrow Involvement

A. N. Zenkov, V. Vlassov, E. Chernolovskaya, 2004, Nucleosides, nucleotides & nucleic acids.

Tropism of Extracellular Vesicles and Cell-Derived Nanovesicles to Normal and Cancer Cells: New Perspectives in Tumor-Targeted Nucleic Acid Delivery

V. Vlassov, M. Zenkova, A. Chernonosov, 2021, Pharmaceutics.

Hybridization of antisense oligonucleotides with yeast tRNAPhe: factors determining the efficiency of interaction

V. Vlassov, V. Petyuk, M. Zenkova, 2002 .

Mechanism of oligonucleotide hybridization with the 3′-terminal region of the yeast tRNAPhe

V. Vlassov, R. Giegé, V. Petyuk, 2000, Molecular Biology.

Uptake of oligonucleotides by keratinocytes.

E. Vivés, V. Vlassov, J. Piette, 1999, Nucleosides & nucleotides.

Antitumor Vaccines Based on Dendritic Cells: From Experiments using Animal Tumor Models to Clinical Trials

V. Vlassov, M. Zenkova, O. V. Markov, 2017, Acta naturae.

Extra Purified Exosomes from Human Placenta Contain an Unpredictable Small Number of Different Major Proteins

V. Vlassov, P. Dmitrenok, E. Ryabchikova, 2019, International Journal of Molecular Sciences.

Nonenzymatic Recombination of RNA: Possible Mechanism for the Formation of Novel Sequences

V. Vlassov, M. Zenkova, A. Lutay, 2007, Chemistry & biodiversity.

Cell Surface Oligonucleotide-Binding Proteins of Human Squamous Carcinoma A431 Cells

D. Pyshnyi, V. Vlassov, B. Chelobanov, 2003, Nucleosides, nucleotides & nucleic acids.

Interaction of oligonucleotides with cellular proteins.

V. Vlassov, B. Chelobanov, P. Laktionov, 2001, Nucleosides, Nucleotides & Nucleic Acids.

Peptide-oligonucleotide conjugates exhibiting pyrimidine-X cleavage specificity efficiently silence miRNA target acting synergistically with RNase H

D. Pyshnyi, V. Vlassov, M. A. Bazhenov, 2018, Scientific Reports.

Artificial ribonucleases inactivate a wide range of viruses using their ribonuclease, membranolytic, and chaotropic-like activities.

V. Vlassov, M. Zenkova, V. Silnikov, 2016, Antiviral research.

Covalently attached oligodeoxyribonucleotides induce RNase activity of a short peptide and modulate its base specificity.

V. Vlassov, H. Gross, M. Zenkova, 2004, Nucleic acids research.

Sequence-specific RNA cleavage by oligonucleotide-peptide conjugates

D. Pyshnyi, V. Vlassov, H. Gross, 2002 .

DESIGN OF RIBONUCLEASE MIMICS FOR SEQUENCE SPECIFIC CLEAVAGE OF RNA

V. Vlassov, R. Giegé, G. Zuber, 1996 .

Hybridization of Antisense Oligonucleotides with α‐Sarcin Loop Region of Escherichia coli 23S rRNA

V. Vlassov, V. Petyuk, M. Zenkova, 2004 .

NUCLEOSIDES, NUCLEOTIDES & NUCLEIC ACIDS

D. Pyshnyi, V. Vlassov, M. Zenkova, 2004 .

Ribonuclease Activity of the Peptides with Alternating Arginine and Leucine Residues Conjugated to Tetrathymidilate

D. Pyshnyi, V. Vlassov, M. Zenkova, 2004, Nucleosides, nucleotides & nucleic acids.

Hybridization of antisense oligonucleotides with the 3′ part of tRNAPhe

V. Vlassov, R. Giegé, V. Petyuk, 1999 .

Nonenzymatic recombination of RNA by means of transesterification

V. Vlassov, I. Grigoriev, M. Zenkova, 2007 .

RNA cleavage by 1,4-diazabicyclo[2.2.2]octane-imidazole conjugates.

V. Vlassov, R. Giegé, M. Zenkova, 2001, Methods in enzymology.

Chemical Ribonucleases: 4.1 An Analysis of the Domain Structure of Chemical Ribonucleases Based on 1,4-Diazabicyclo[2.2.2]octane

V. Vlassov, M. Zenkova, V. Silnikov, 2002, Russian Journal of Bioorganic Chemistry.

Circulating DNA in the Blood of Gastric Cancer Patients

V. Vlassov, P. Laktionov, E. Rykova, 2008, Annals of the New York Academy of Sciences.

A comparative study of cell-free apoptotic and genomic DNA using FISH and massive parallel sequencing

A. Kurilshikov, V. Vlassov, P. Laktionov, 2012, Expert opinion on biological therapy.

Cell-Surface-Bound DNA Inhibits Poly(I:C)-Activated IL-6 and IL-8 Production in Human Primary Endothelial Cells and Fibroblasts

V. Vlassov, P. Laktionov, A. V. Bushuev, 2010 .

Non-enzymatic recombination of RNA: Ligation in loops.

V. Vlassov, R. Bryce, M. Zenkova, 2017, Biochimica et biophysica acta. General subjects.

Binding and Penetration of Methylated DNA into Primary and Transformed Human Cells

V. Vlassov, P. Laktionov, T. Skvortsova, 2008, Annals of the New York Academy of Sciences.

Reactive oligonucleotide derivatives and sequence-specific modification of nucleic acids.

V. Vlassov, V. Zarytova, D. Knorre, 1985, Biochimie.

Heavy-light chain interrelations of MS-associated immunoglobulins probed by deep sequencing and rational variation.

Alexander V. Favorov, V. Vlassov, Y. Medvedeva, 2014, Molecular immunology.

The nonenzymatic template-directed ligation of oligonucleotides

V. Vlassov, M. Zenkova, E. Chernolovskaya, 2006 .